Royal Bank of Canada Lowers Xencor (NASDAQ:XNCR) Price Target to $32.00

Xencor (NASDAQ:XNCR – Free Report) had its target price trimmed by Royal Bank of Canada from $36.00 to $32.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The brokerage currently has an outperform rating on the biopharmaceutical company’s stock. A number of other research analysts have also commented on XNCR. Piper […]

Leave a Reply

Your email address will not be published.

Previous post Cameco (TSE:CCO) PT Raised to C$68.00 at BMO Capital Markets
Next post Sovos Brands (NASDAQ:SOVO) Cut to “Market Perform” at Telsey Advisory Group